NWBO
Price:
$0.26
Market Cap:
$337.34M
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.[Read more]
Industry
Biotechnology
IPO Date
2001-12-14
Stock Exchange
PNK
Ticker
NWBO
According to Northwest Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.09. This represents a change of 0.70% compared to the average of 0.09 of the last 4 quarters.
The mean historical Current Ratio of Northwest Biotherapeutics, Inc. over the last ten years is 0.15. The current 0.09 Current Ratio has changed 5.88% with respect to the historical average. Over the past ten years (40 quarters), NWBO's Current Ratio was at its highest in in the December 2015 quarter at 0.37. The Current Ratio was at its lowest in in the March 2018 quarter at 0.01.
Average
0.15
Median
0.10
Minimum
0.02
Maximum
0.37
Discovering the peaks and valleys of Northwest Biotherapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.03%
Maximum Annual Current Ratio = 0.37
Minimum Annual Increase = -84.50%
Minimum Annual Current Ratio = 0.02
Year | Current Ratio | Change |
---|---|---|
2023 | 0.09 | 22.00% |
2022 | 0.07 | -42.13% |
2021 | 0.13 | 218.67% |
2020 | 0.04 | -47.79% |
2019 | 0.08 | -77.20% |
2018 | 0.34 | 2.03% |
2017 | 0.02 | -84.50% |
2016 | 0.10 | -72.26% |
2015 | 0.37 | 75.00% |
2014 | 0.21 | -77.55% |
The current Current Ratio of Northwest Biotherapeutics, Inc. (NWBO) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
0.10
5-year avg
0.08
10-year avg
0.15
Northwest Biotherapeutics, Inc.’s Current Ratio is greater than ImmunoCellular Therapeutics, Ltd. (0), less than Celldex Therapeutics, Inc. (24.27), less than CEL-SCI Corporation (0.64), less than OncoSec Medical Incorporated (2.30), less than Advaxis, Inc. (0.30),
Company | Current Ratio | Market cap |
---|---|---|
0 | $19.14M | |
24.27 | $1.67B | |
0.64 | $45.43M | |
2.30 | $1.65M | |
0.30 | $1.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Northwest Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Northwest Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Northwest Biotherapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Northwest Biotherapeutics, Inc. (NWBO)?
What is the highest Current Ratio for Northwest Biotherapeutics, Inc. (NWBO)?
What is the 3-year average Current Ratio for Northwest Biotherapeutics, Inc. (NWBO)?
What is the 5-year average Current Ratio for Northwest Biotherapeutics, Inc. (NWBO)?
How does the current Current Ratio for Northwest Biotherapeutics, Inc. (NWBO) compare to its historical average?